184 related articles for article (PubMed ID: 25196735)
1. Morphine and DAMGO produce an opposite effect on presynaptic glutamate release via different downstream pathways of μ opioid receptors in the basolateral amygdala.
Yang J; Yang H; Du X; Ma Q; Song J; Chen M; Dong Y; Ma L; Zheng P
Neuropharmacology; 2014 Nov; 86():353-61. PubMed ID: 25196735
[TBL] [Abstract][Full Text] [Related]
2. DAMGO depresses inhibitory synaptic transmission via different downstream pathways of μ opioid receptors in ventral tegmental area and periaqueductal gray.
Zhang W; Yang HL; Song JJ; Chen M; Dong Y; Lai B; Yu YG; Ma L; Zheng P
Neuroscience; 2015 Aug; 301():144-54. PubMed ID: 26047721
[TBL] [Abstract][Full Text] [Related]
3. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord.
Zhou HY; Chen SR; Chen H; Pan HL
J Pharmacol Exp Ther; 2008 Nov; 327(2):375-82. PubMed ID: 18669865
[TBL] [Abstract][Full Text] [Related]
4. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons.
Zhu W; Pan ZZ
Neuroscience; 2005; 133(1):97-103. PubMed ID: 15893634
[TBL] [Abstract][Full Text] [Related]
5. DAMGO suppresses both excitatory and inhibitory synaptic transmission in supraoptic neurones of mouse hypothalamic slice preparations.
Honda E; Ono K; Inenaga K
J Neuroendocrinol; 2004 Mar; 16(3):198-207. PubMed ID: 15049850
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic actions of opioid receptor agonists in ventromedial hypothalamic neurons in estrogen- and oil-treated female mice.
Devidze N; Zhang Q; Zhou J; Lee AW; Pataky S; Kow LM; Pfaff DW
Neuroscience; 2008 Apr; 152(4):942-9. PubMed ID: 18343595
[TBL] [Abstract][Full Text] [Related]
7. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation.
Marek GJ; Aghajanian GK
Neuroscience; 1998 Sep; 86(2):485-97. PubMed ID: 9881863
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of N- and P/Q-type Ca2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons.
Wu ZZ; Chen SR; Pan HL
J Pharmacol Exp Ther; 2004 Dec; 311(3):939-47. PubMed ID: 15280436
[TBL] [Abstract][Full Text] [Related]
10. Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/1.2 channels.
Finnegan TF; Chen SR; Pan HL
J Neurophysiol; 2006 Apr; 95(4):2032-41. PubMed ID: 16306173
[TBL] [Abstract][Full Text] [Related]
11. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.
Finnegan TF; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784
[TBL] [Abstract][Full Text] [Related]
12. Enkephalinergic inhibition of raphe pallidus inputs to rat hypoglossal motoneurones in vitro.
Bouryi VA; Lewis DI
Neuroscience; 2004; 129(1):55-64. PubMed ID: 15489028
[TBL] [Abstract][Full Text] [Related]
13. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
14. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
15. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
16. Chronic morphine selectively sensitizes the effect of D1 receptor agonist on presynaptic glutamate release in basolateral amygdala neurons that project to prelimbic cortex.
Song J; Chen M; Dong Y; Lai B; Zheng P
Neuropharmacology; 2018 May; 133():375-384. PubMed ID: 29427651
[TBL] [Abstract][Full Text] [Related]
17. Opioid mu receptor activation inhibits sodium currents in prefrontal cortical neurons via a protein kinase A- and C-dependent mechanism.
Witkowski G; Szulczyk P
Brain Res; 2006 Jun; 1094(1):92-106. PubMed ID: 16733049
[TBL] [Abstract][Full Text] [Related]
18. Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala.
Shin MS; Helmstetter FJ
Brain Res; 2005 Dec; 1064(1-2):56-65. PubMed ID: 16289487
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord.
Chen W; Ennes HS; McRoberts JA; Marvizón JC
Neuropharmacology; 2018 Jan; 128():255-268. PubMed ID: 29042318
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal.
Manzoni OJ; Williams JT
J Neurosci; 1999 Aug; 19(15):6629-36. PubMed ID: 10414991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
